Insider Transactions in Q1 2025 at Mirum Pharmaceuticals, Inc. (MIRM)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
2,415
-49.89%
|
$106,260
$44.45 P/Share
|
|
Mar 17
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
27,279
-16.44%
|
$1,200,276
$44.21 P/Share
|
|
Mar 17
2025
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
7,879
-29.68%
|
$346,676
$44.21 P/Share
|
|
Mar 17
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
57,606
-42.81%
|
$2,534,664
$44.41 P/Share
|
|
Mar 17
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
52,900
+47.04%
|
$105,800
$2.94 P/Share
|
|
Mar 17
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
21
+0.01%
|
$903
$43.93 P/Share
|
|
Mar 15
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+23.16%
|
-
|
|
Mar 15
2025
|
Peter Radovich PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,440
+35.23%
|
-
|
|
Mar 15
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,315
+35.76%
|
-
|
|
Mar 14
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
528
+0.31%
|
$23,232
$44.11 P/Share
|
|
Mar 11
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
963
+0.57%
|
$41,409
$43.77 P/Share
|
|
Mar 10
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
1,335
+0.4%
|
$57,405
$43.01 P/Share
|
|
Mar 07
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
580
+0.35%
|
$24,940
$43.21 P/Share
|
|
Mar 06
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
1,335
+0.8%
|
$57,405
$43.89 P/Share
|
|
Mar 05
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
267
+0.16%
|
$11,748
$44.55 P/Share
|
|
Mar 04
2025
|
Patrick J Heron |
BUY
Open market or private purchase
|
Indirect |
1,335
+0.41%
|
$60,075
$45.75 P/Share
|
|
Mar 04
2025
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
14,850
-29.77%
|
$668,250
$45.66 P/Share
|
|
Mar 03
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
40,000
-13.77%
|
$1,840,000
$46.9 P/Share
|
|
Mar 03
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
40,000
+20.42%
|
$80,000
$2.94 P/Share
|
|
Feb 03
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
1,064
-20.09%
|
$51,072
$48.22 P/Share
|
|
Feb 03
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
9,102
-7.28%
|
$436,896
$48.22 P/Share
|
|
Feb 03
2025
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
2,627
-8.88%
|
$126,096
$48.22 P/Share
|
|
Jan 31
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,772
+25.07%
|
-
|
|
Jan 24
2025
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
3,177
-9.7%
|
$149,319
$47.92 P/Share
|
|
Jan 24
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
6,837
-5.19%
|
$321,339
$47.92 P/Share
|
|
Jan 24
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
902
-20.38%
|
$42,394
$47.92 P/Share
|
|
Jan 23
2025
|
Eric Bjerkholt CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,667
+6.91%
|
-
|
|
Jan 23
2025
|
Peter Radovich PRESIDENT AND COO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,750
+14.93%
|
-
|
|
Jan 23
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+8.66%
|
-
|
|
Jan 23
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+25.31%
|
-
|
|
Jan 17
2025
|
Joanne Quan CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,969
-55.23%
|
$313,605
$45.86 P/Share
|
|
Jan 16
2025
|
Joanne Quan CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+49.77%
|
-
|
|
Jan 07
2025
|
Christopher Peetz CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
7,489
-5.9%
|
$314,538
$42.82 P/Share
|
|
Jan 07
2025
|
Peter Radovich PRESIDENT AND COO |
SELL
Open market or private sale
|
Direct |
1,998
-6.89%
|
$83,916
$42.82 P/Share
|
|
Jan 07
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
SELL
Open market or private sale
|
Direct |
750
-20.4%
|
$31,500
$42.82 P/Share
|
|
Jan 06
2025
|
Jolanda Howe SVP, GLOBAL CONTROLLER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+25.38%
|
-
|